Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPVST Cells in Relapsed HPV-Associated Cancers
NCT02379520Phase 1Completed
- Sponsor
- Baylor College of Medicine
- Start
- Sep 2015
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial in human papillomavirus-related carcinoma (2 arms), sponsored by Baylor College of Medicine. Primary endpoint: Dose Limiting Toxicity at 6 weeks. Started Sep 2015; status: completed.
02
Conditions
human papillomavirus-related carcinoma
Beyond the preview
Go deeper on NCT02379520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02379520.